Christopher Causey

Director

Christopher Causey (Director) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in United Therapeutics Corporation (UTHR). The largest single filing was $786K of UTHR (1,300 sh × $604.64, as filed), executed Mar 30.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.3M

shares × price, as filed

Last traded

Mar 30

Filed Mar 31

Median ADV $265.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $4.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

UTHR

United Therapeutics Corporation UTHR · 0 buys · 7 sells 7 filings

Recent filings

UTHRSALE United Therapeutics Corporation View filing → $786K
1,300 sh × $604.64
Exec Mar 30
Filed Mar 31 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $520K
1,000 sh × $520.00
Exec Feb 25
Filed Feb 25 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $510K
1,000 sh × $510.00
Exec Jan 6
Filed Jan 6 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $500K
1,000 sh × $500.01
Exec Jan 2
Filed Jan 5 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $440K
1,000 sh × $440.00
Exec Sep 24 2025
Filed Sep 25 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $1.3M
3,000 sh across 3 lots
Exec Sep 2 2025
Filed Sep 2 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $192K
510 sh × $376.63
Exec Nov 1 2024
Filed Nov 4 2024 · 5:30 PM ET